+
Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

What are your goals for visiting NephU?(Required)
How would you like to hear from us?(Required)
Agree(Required)

Prognostic Tools

Learn from Dr Lerma about the MEST-C score and how it is used to assess the risk of IgAN progression.

https://vimeo.com/1113919808?share=copy

Learn more about the evolving clinical approach to IgAN:

References:

Barbour SJ, et al. Kidney Int. 2022;102(1):160-172.

KDIGO. Kidney Int. 2021;100:S1-S276.

Pattrapornpisut P, et al. Am J Kidney Dis. 2021;78(3):429-441.

Join NephU today at no cost for access to this and other premium content!

We’re collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions. NephU is a growing community where nephrology health care professionals engage, collaborate, and utilize resources to help improve future outcomes for those with kidney disease and other related conditions.

Join Today for Instant Access to all NephU Offerings.

Membership is free!